JPWO2019169342A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2019169342A5 JPWO2019169342A5 JP2020545532A JP2020545532A JPWO2019169342A5 JP WO2019169342 A5 JPWO2019169342 A5 JP WO2019169342A5 JP 2020545532 A JP2020545532 A JP 2020545532A JP 2020545532 A JP2020545532 A JP 2020545532A JP WO2019169342 A5 JPWO2019169342 A5 JP WO2019169342A5
- Authority
- JP
- Japan
- Prior art keywords
- oxytocin peptide
- labeled
- composition
- labeled oxytocin
- oxytocin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024009405A JP2024038482A (ja) | 2018-03-01 | 2024-01-25 | 標識オキシトシンならびに製造および使用の方法 |
| JP2025230634A JP2026035830A (ja) | 2018-03-01 | 2025-12-04 | 標識オキシトシンならびに製造および使用の方法 |
| JP2025230635A JP2026035831A (ja) | 2018-03-01 | 2025-12-04 | 標識オキシトシンならびに製造および使用の方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862637187P | 2018-03-01 | 2018-03-01 | |
| US62/637,187 | 2018-03-01 | ||
| PCT/US2019/020419 WO2019169342A1 (en) | 2018-03-01 | 2019-03-01 | Labeled oxytocin and method of manufacture and use |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024009405A Division JP2024038482A (ja) | 2018-03-01 | 2024-01-25 | 標識オキシトシンならびに製造および使用の方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021515005A JP2021515005A (ja) | 2021-06-17 |
| JPWO2019169342A5 true JPWO2019169342A5 (https=) | 2022-03-07 |
| JP2021515005A5 JP2021515005A5 (https=) | 2022-03-07 |
Family
ID=65763911
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020545532A Pending JP2021515005A (ja) | 2018-03-01 | 2019-03-01 | 標識オキシトシンならびに製造および使用の方法 |
| JP2024009405A Withdrawn JP2024038482A (ja) | 2018-03-01 | 2024-01-25 | 標識オキシトシンならびに製造および使用の方法 |
| JP2025230635A Pending JP2026035831A (ja) | 2018-03-01 | 2025-12-04 | 標識オキシトシンならびに製造および使用の方法 |
| JP2025230634A Pending JP2026035830A (ja) | 2018-03-01 | 2025-12-04 | 標識オキシトシンならびに製造および使用の方法 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024009405A Withdrawn JP2024038482A (ja) | 2018-03-01 | 2024-01-25 | 標識オキシトシンならびに製造および使用の方法 |
| JP2025230635A Pending JP2026035831A (ja) | 2018-03-01 | 2025-12-04 | 標識オキシトシンならびに製造および使用の方法 |
| JP2025230634A Pending JP2026035830A (ja) | 2018-03-01 | 2025-12-04 | 標識オキシトシンならびに製造および使用の方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US11970554B2 (https=) |
| EP (1) | EP3759121A1 (https=) |
| JP (4) | JP2021515005A (https=) |
| WO (1) | WO2019169342A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3759121A1 (en) * | 2018-03-01 | 2021-01-06 | Trigemina, Inc. | Labeled oxytocin and method of manufacture and use |
| US11631208B1 (en) * | 2021-12-22 | 2023-04-18 | RealizeMD Ltd. | Systems and methods for generating clinically relevant images that preserve physical attributes of humans while protecting personal identity |
| US11935238B2 (en) * | 2021-12-22 | 2024-03-19 | RealizeMD Ltd. | Systems and methods for generating clinically relevant images that preserve physical attributes of humans while protecting personal identity |
| US12440454B2 (en) | 2022-02-01 | 2025-10-14 | Portland Technology Holdings Llc | Pharmaceutical compositions containing hemp extract for administration to felines and related methods |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1936364A (en) | 1930-08-22 | 1933-11-21 | Pfizer Charles & Co | Citrate solutions |
| US2260004A (en) | 1939-11-03 | 1941-10-21 | Pfizer Charles & Co | Stable soluble magnesium acid citrate |
| US2938891A (en) | 1956-03-30 | 1960-05-31 | Roussel Uclaf | Method of making oxytocin and intermediates thereof |
| US3076797A (en) | 1957-07-22 | 1963-02-05 | Roussel Uclaf | Process of producing oxytocin and intermediates obtained thereby |
| DE19627228A1 (de) | 1996-07-05 | 1998-01-08 | Pfeiffer Erich Gmbh & Co Kg | Austragvorrichtung für Medien |
| GB0209494D0 (en) | 2002-04-25 | 2002-06-05 | Optinose As | Nasal devices |
| JP2004161664A (ja) | 2002-11-13 | 2004-06-10 | Fancl Corp | プロポリス組成物 |
| WO2004062563A2 (en) * | 2003-01-16 | 2004-07-29 | Université de Lausanne | Methods for screening for therapeutic agents that are useful in the treatment of oxytocin and vasopressin-related disorders |
| GB0319119D0 (en) | 2003-08-14 | 2003-09-17 | Optinose As | Delivery devices |
| JP2007526300A (ja) * | 2004-03-04 | 2007-09-13 | ジーイー・ヘルスケア・アクスイェ・セルスカプ | 医薬化合物 |
| MX2007003750A (es) | 2004-09-29 | 2007-11-07 | Ge Healthcare As | Agentes de contraste enfocadores del receptor activador de plasminogeno de urocinasa (upar). |
| CA2689476C (en) | 2007-06-07 | 2014-08-05 | Nastech Pharmaceutical Company Inc. | Intranasal carbetocin formulations and methods for the treatment of autism |
| JP2010085108A (ja) * | 2008-09-29 | 2010-04-15 | Nano Factory:Kk | 生体光イメージング用プローブ |
| EP2416806B8 (en) * | 2009-04-10 | 2017-03-15 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Fucoidans as ligands for the diagnosis of degenerative pathologies |
| JP2013521233A (ja) * | 2010-02-25 | 2013-06-10 | ヤンセン アルツハイマー イミュノセラピー | Ａβを標的とする免疫療法のＰＥＴモニタリング |
| US20130130985A1 (en) | 2010-04-01 | 2013-05-23 | Paul Alewood | Oxytocin peptide analogues |
| JP2013230986A (ja) * | 2010-08-25 | 2013-11-14 | Kyorin Pharmaceutical Co Ltd | 新規ヒダントイン誘導体及びそれらを有効成分とする医薬 |
| JO3400B1 (ar) | 2010-09-30 | 2019-10-20 | Ferring Bv | مركب صيدلاني من كاربيتوسين |
| JP6445861B2 (ja) | 2014-12-18 | 2018-12-26 | 国立大学法人金沢大学 | オキシトシン検出のためのサンプルの前処理方法 |
| SG11201705591PA (en) | 2015-01-07 | 2017-08-30 | Trigemina Inc | Magnesium-containing oxytocin formulations and methods of use |
| WO2017096036A1 (en) | 2015-12-02 | 2017-06-08 | The Regents Of The University Of Michigan | Her2 peptide regents and methods |
| EP3759121A1 (en) | 2018-03-01 | 2021-01-06 | Trigemina, Inc. | Labeled oxytocin and method of manufacture and use |
-
2019
- 2019-03-01 EP EP19710979.6A patent/EP3759121A1/en active Pending
- 2019-03-01 WO PCT/US2019/020419 patent/WO2019169342A1/en not_active Ceased
- 2019-03-01 US US16/976,912 patent/US11970554B2/en active Active
- 2019-03-01 JP JP2020545532A patent/JP2021515005A/ja active Pending
-
2024
- 2024-01-25 JP JP2024009405A patent/JP2024038482A/ja not_active Withdrawn
- 2024-03-29 US US18/621,985 patent/US12466855B2/en active Active
-
2025
- 2025-12-04 JP JP2025230635A patent/JP2026035831A/ja active Pending
- 2025-12-04 JP JP2025230634A patent/JP2026035830A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021515005A5 (https=) | ||
| CN104812384B (zh) | 二取代的氨基酸及其制备和使用方法 | |
| Hay et al. | Quantitative structure-stability relationship for potassium ion complexation by crown ethers. A molecular mechanics and ab initio study | |
| Yang et al. | Structure and isomerization of an intrastrand cisplatin-cross-linked octamer DNA duplex by NMR analysis | |
| US20170349638A1 (en) | Companion diagnostic tool for peptidomimetic macrocycles | |
| JP2021532784A5 (https=) | ||
| CA2673853A1 (en) | Ligands for imaging cardiac innervation | |
| NO328049B1 (no) | Sammensetning omfattende et DTPA-derivat samt anvendelse derav | |
| JPWO2019169342A5 (https=) | ||
| CN110740994A (zh) | 具有受正交保护的酯部分的肽核酸(pna)单体 | |
| JP5750209B2 (ja) | 機能性分子、機能性分子合成用アミダイド、及び標的物質解析方法 | |
| Drozdzal et al. | Ultrahigh-resolution crystal structures of Z-DNA in complex with Mn2+ and Zn2+ ions | |
| Ikeda et al. | The secondary structure of a heptapeptide containing trifluoromethyl-λ 6-tetrafluorosulfanyl substituted amino acids | |
| CA2662439A1 (en) | Compounds as aptamer-dimers and their uses in diagnosis and therapy | |
| CN103370084B (zh) | 苯胺在肟连接的放射稳定化中的应用 | |
| AU2016335061A1 (en) | New methods for making barusiban and its intermediates | |
| CN112154131A (zh) | 稳定化的放射标记反应 | |
| Wester | 42 18 F: Labeling Chemistry and Labeled Compounds | |
| AU2018298658B2 (en) | Improved process for preparing imetelstat | |
| CN114901673A (zh) | 溶液相肽核酸寡聚体的制备方法 | |
| Guidoni et al. | Hybrid Car‐Parrinello/Molecular Mechanics Modelling of Transition Metal Complexes: Structure, Dynamics and Reactivity | |
| Sanghvi et al. | Chemical synthesis and purification of phosphorothioate antisense oligonucleotides | |
| Kriek et al. | Chemical synthesis of picornaviral protein primers of RNA replication | |
| EP3539970B1 (en) | Polymerizable compound, compound, and method for producing boranophosphate oligomer | |
| EP2774930A1 (en) | Metallocene compounds and labeled molecules comprising the same for in vivo imaging. |